ChemicalBook Product Catalog Pharmaceutical intermediates Bulk Drug Intermediates 8-Benzyloxy-5-((R)-2-broMo-1-hydroxyethyl)-1H-quinolinone

8-Benzyloxy-5-((R)-2-broMo-1-hydroxyethyl)-1H-quinolinone

8-Benzyloxy-5-((R)-2-broMo-1-hydroxyethyl)-1H-quinolinone Basic information
Product Name:8-Benzyloxy-5-((R)-2-broMo-1-hydroxyethyl)-1H-quinolinone
Synonyms:8-benzyloxy-5((R)-2-broMo-1-hydroxyethyl)-2-(1H-)-quinolinone;(R)-8-Benzyloxy-5-(2-broMo-1-hydroxyethyl)carbostyril;5-(2-BroMo-(R)-1-hydroxyethyl)-8-benzyloxy-2(1H)-quinolinone;5-[(1R)-2-BroMo-1-hydroxyethyl]-8-(phenylMethoxy)-2(1H)-quinolinone;8-(Benzylox;(R)-8-(Benzyloxy)-5-(2-broMo-1-hydroxyethyl)quinolin-2(1H)-one;8-Benzyloxy-5((R)-2-broMo-1-hydroxyethyl)-2-(1H)-quinoline;8-Benzyloxy-5-((R)-2-broMo-1-hydroxyethyl)-1H-quinolin-2-one
CAS:530084-79-8
MF:C18H16BrNO3
MW:374.23
EINECS:
Product Categories:Aromatics;Chiral Reagents;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals
Mol File:530084-79-8.mol
8-Benzyloxy-5-((R)-2-broMo-1-hydroxyethyl)-1H-quinolinone Structure
8-Benzyloxy-5-((R)-2-broMo-1-hydroxyethyl)-1H-quinolinone Chemical Properties
Melting point >153oC (dec.)
Boiling point 595.8±50.0 °C(Predicted)
density 1.490±0.06 g/cm3(Predicted)
storage temp. Inert atmosphere,Room Temperature
solubility DMSO (Slightly), Ethyl Acetate (Slightly)
form Solid
pka10.78±0.70(Predicted)
color Light Beige
Safety Information
MSDS Information
8-Benzyloxy-5-((R)-2-broMo-1-hydroxyethyl)-1H-quinolinone Usage And Synthesis
Chemical PropertiesLight Brown Solid
Uses8-Benzyloxy-5-((R)-2-bromo-1-hydroxyethyl)-1H-quinolinone is used in the preparation of phenylethanolamine derivatives as β2 adrenoreceptor agonists.
8-Benzyloxy-5-((R)-2-broMo-1-hydroxyethyl)-1H-quinolinone Preparation Products And Raw materials
Preparation Products12401-->(8-(benzyloxy)-5-[(1R)-2-broMo-1-{[tert-butyl(diMethyl)silyl]oxy}ethyl]quinolin-2(1H)-one )
Indacaterol Impurity 12 Indacaterol Impurity 3 2(1H)-Quinolinone, 5,5'-[[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)imino]bis(1-hydroxy-2,1-ethanediyl)]bis[8-(phenylmethoxy)- 2(1H)-Quinolinone, 5-[(1S)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-(phenylmethoxy)- N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine β-D-Glucopyranuronic acid, 1-deoxy-1-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)[(2R)-2-(1,2-dihydro-8-hydroxy-2-oxo-5-quinolinyl)-2-hydroxyethyl]amino]- Indacaterol interMediate BENZYLOXYACETALDEHYDE Indacaterol Impurity 13 (Mixture of Diastereomers) 2(1H)-Quinolinone, 8-hydroxy-5-[(1R,2R)-1-hydroxy-2-[(1-methylethyl)amino]butyl]-, rel- 5-ACETYL-8-HYDROXY-1H-QUINOLIN-2-ONE Indacaterol Impurity 22 2-Aminoindan hydrochloride Procaterolhydrochloridehemidrate 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid 5-Acetyl-8-(phenylmethoxy)-2-quinolinone Indacaterol Impurity 34 8-HYDROXY-QUINOLINE-5-CARBALDEHYDE
Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.